Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population.

Autor: Piekarska A; Department of Infectious Diseases and Hepatology, Medical University of Lodz, Poland., Koślińska-Berkan E; Department of Infectious Diseases and Hepatology, Medical University of Lodz, Poland., Wójcik K; Department of Infectious Diseases and Hepatology, Medical University of Lodz, Poland., Skubała A; Department of Infectious Diseases and Hepatology, Medical University of Lodz, Poland., Jabłkowski M; Department of Infectious and Liver Diseases, Medical University of Lodz, Poland., Deroń Z; Observation - Infectious and Hepatology Department, Bieganski Voivodship Specialist Hospital in Lodz, Poland., Berkan-Kawińska A; Department of Infectious Diseases and Hepatology, Medical University of Lodz, Poland.

Publikováno v: Clinical and experimental hepatology [Clin Exp Hepatol] 2016 Dec; Vol. 2 (4), pp. 133-137. Date of Electronic Publication: 2016 Nov 28.